Start-up
Anjarium Biosciences AG
About Anjarium Biosciences
At Anjarium Biosciences, we are striving to create and deliver solutions for patients beyond what current gene therapy platforms address today. We do this by tackling more diseases, more precisely and in a more personalized way. Anjarium is developing a new generation of genetic medicines to overcome the greatest challenges facing the field, notably immunogenicity, payload capacity, individualized multiple dosing, targeted delivery and scaled manufacturing.
- Founding: 2017
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology, Pharma
Here you will find Anjarium Biosciences AG
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
